Regenerative medicine startup born out of Johns Hopkins closes $29M round

Baltimore's LifeSprout plans to use the new funding to move its first product through clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.